AMLOGENYX INC.

Profile

Company Names

AMLOGENYX INC.

Addresses

77 DIGITAL DRIVE, SUITE 200, NOVATO, CA 94949

Phone Numbers

415-483-8800

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2023

State Incorporated:

DELAWARE

Total Amount Raised:

$23,999,989.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2026-07-01 
$10,000,000.00 
$20,000,000.00 
$10,000,000.00 
 
1
2024-07-26 
$13,999,989.00 
$13,999,989.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CRAIG 
 
GORDON 
DIRECTOR
OTR GLOBAL HOLDINGS II, INC.   |  KOLLECTIVE TECHNOLOGY, INC.   |  ANTIOS THERAPEUTICS INC.   |  SALIOGEN THERAPEUTICS, INC.   |  GENNAO BIO, INC.   |  AMLOGENYX INC.   |  RAPALOGIX HEALTH, INC.
TED 
 
HUIZENGA 
EXECUTIVE OFFICER
AMLOGENYX INC.
EMIL 
 
KAKKIS 
EXECUTIVE OFFICER, DIRECTOR
ULTRAGENYX PHARMACEUTICAL INC.   |  AMLOGENYX INC.
TOM 
 
KASSBERG 
EXECUTIVE OFFICER
AMLOGENYX INC.
SUKUMAR 
 
NAGENDRAN 
DIRECTOR
AVEXIS, INC.   |  SOLID BIOSCIENCES INC.   |  TAYSHA GENE THERAPIES, INC.   |  SALIOGEN THERAPEUTICS, INC.   |  AMLOGENYX INC.
KARAH 
 
PARSCHAUER 
EXECUTIVE OFFICER
EVOLUS, INC.   |  ANEBULO PHARMACEUTICALS, INC.   |  AMLOGENYX INC.
JOHN 
 
PINION 
EXECUTIVE OFFICER
AMLOGENYX INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-07-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2026-07-01 
2024-08-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#